Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.

Fabis-Pedrini MJ, James I, Seewann A, Yau WY, van de Bovenkamp AA, Sanders FRK, Qiu W, Burton J, Mastaglia FL, Carroll WM, Kermode AG.

J Neurol Sci. 2018 May 15;388:12-18. doi: 10.1016/j.jns.2018.02.036. Epub 2018 Feb 22.

PMID:
29627005
2.

Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.

Pedrini MJ, Seewann A, Bennett KA, Wood AJ, James I, Burton J, Marshall BJ, Carroll WM, Kermode AG.

J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):603-7. doi: 10.1136/jnnp-2014-309495. Epub 2015 Jan 19.

PMID:
25602009
3.

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

Wallner-Blazek M, Rovira A, Fillipp M, Rocca MA, Miller DH, Schmierer K, Frederiksen J, Gass A, Gama H, Tilbery CP, Rocha AJ, Flores J, Barkhof F, Seewann A, Palace J, Yousry T, Montalban X, Enzinger C, Fazekas F.

J Neurol. 2013 Aug;260(8):2016-22. doi: 10.1007/s00415-013-6918-y. Epub 2013 Apr 26.

PMID:
23620065
4.

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.

Vennegoor A, Rispens T, Strijbis EM, Seewann A, Uitdehaag BM, Balk LJ, Barkhof F, Polman CH, Wolbink G, Killestein J.

Mult Scler. 2013 Apr;19(5):593-600. doi: 10.1177/1352458512460604. Epub 2012 Sep 19.

PMID:
22992450
5.

Postmortem verification of MS cortical lesion detection with 3D DIR.

Seewann A, Kooi EJ, Roosendaal SD, Pouwels PJ, Wattjes MP, van der Valk P, Barkhof F, Polman CH, Geurts JJ.

Neurology. 2012 Jan 31;78(5):302-8. doi: 10.1212/WNL.0b013e31824528a0. Epub 2012 Jan 4.

PMID:
22218278
6.

Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis.

Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.

Mult Scler. 2011 Oct;17(10):1202-10. doi: 10.1177/1352458511406575. Epub 2011 May 11.

PMID:
21561955
7.

No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study.

Wattjes MP, van Oosten BW, de Graaf WL, Seewann A, Bot JC, van den Berg R, Uitdehaag BM, Polman CH, Barkhof F.

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):429-35. doi: 10.1136/jnnp.2010.223479. Epub 2010 Oct 27.

PMID:
20980483
8.

Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ.

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):126-35. doi: 10.1136/jnnp.2009.204685. Epub 2010 Oct 9. Review.

PMID:
20935330
9.

Natalizumab drug holiday in multiple sclerosis: poorly tolerated.

Killestein J, Vennegoor A, Strijbis EM, Seewann A, van Oosten BW, Uitdehaag BM, Polman CH.

Ann Neurol. 2010 Sep;68(3):392-5. doi: 10.1002/ana.22074.

PMID:
20661928
10.

Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types.

Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJ.

AJNR Am J Neuroradiol. 2010 Mar;31(3):541-8. doi: 10.3174/ajnr.A1839. Epub 2009 Oct 22.

11.

Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.

Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.

Arch Neurol. 2009 May;66(5):601-9. doi: 10.1001/archneurol.2009.57.

PMID:
19433660
12.

Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.

Killestein J, Jasperse B, Liedorp M, Seewann A, Polman Ch.

Mult Scler. 2009 Apr;15(4):525-6. doi: 10.1177/1352458508101322. No abstract available.

PMID:
19324985
13.

Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings.

Seewann A, Kooi EJ, Roosendaal SD, Barkhof F, van der Valk P, Geurts JJ.

Acta Neurol Scand. 2009 Jun;119(6):349-55. doi: 10.1111/j.1600-0404.2008.01137.x. Epub 2009 Feb 26. Review.

PMID:
19254283
14.

Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study.

Ropele S, Seewann A, Gouw AA, van der Flier WM, Schmidt R, Pantoni L, Inzitari D, Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, Chabriat H, Ferro J, Hennerici M, O'Brien J, Wallin A, Langhorne P, Visser MC, Barkhof F, Fazekas F; LADIS study group.

J Magn Reson Imaging. 2009 Feb;29(2):268-74. doi: 10.1002/jmri.21580.

PMID:
19161174
15.

Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.

Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ.

Brain. 2008 Dec;131(Pt 12):3286-98. doi: 10.1093/brain/awn265. Epub 2008 Oct 16.

PMID:
18927145
16.

Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.

Vellinga MM, Oude Engberink RD, Seewann A, Pouwels PJ, Wattjes MP, van der Pol SM, Pering C, Polman CH, de Vries HE, Geurts JJ, Barkhof F.

Brain. 2008 Mar;131(Pt 3):800-7. doi: 10.1093/brain/awn009. Epub 2008 Feb 1.

PMID:
18245785
17.

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Seewann A, Enzinger C, Filippi M, Barkhof F, Rovira A, Gass A, Miller D, Montalban X, Thompson A, Yousry T, Tintore M, de Stefano N, Palace J, Rovaris M, Polman C, Fazekas F; MAGNIMS network.

J Neurol. 2008 Jan;255(1):1-10. Epub 2007 Nov 15. Review.

PMID:
18004634
18.

MTI of white matter hyperintensities.

Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, Petrovic K, Schmidt R.

Brain. 2005 Dec;128(Pt 12):2926-32. Epub 2005 Jun 15.

PMID:
15958507
19.

Palliative cytostatic treatment of cervical carcinoma.

Petru E, Benedicic Ch, Seewann A, Pickel H.

Eur J Gynaecol Oncol. 2003;24(6):473-4. Review.

PMID:
14658584

Supplemental Content

Loading ...
Support Center